The reported impact of non-communicable disease investment cases in 13 countries
Non-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-04-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/9/4/e014784.full |
| _version_ | 1797215176540291072 |
|---|---|
| author | Alexey Kulikov Douglas Webb Dudley Tarlton Toker Ergüder Henrik Khachatryan Nicholas Banatvala Anna Kontsevaya Bekir Keskinkilic John Juliard Go Diana Andreasyan Roy Small Aliina Altymysheva Giuseppe Troisi Roman Chestnov Erwin Arthur Phillips Taraleen Malcolm Hero Kol Nargiza Khodjaeva Mussie Gebremichael Addisu Worku Tessema Asmamaw Bezabeh Workneh Tamu Davidson Michelle Harris Nurgul Ibraeva Aigul Nurmatova Krisada Hanbunjerd Sushera Bunluesin Olivia Nieveras Banu Ekinci Oyoo Charles Akiya Hafisa Kasule Aidah Nakanjako Shukhrat Shukurov Nazokat Kasymova Patrick Banda Ernest Kakoma Nathan N Bakyaita Nadia Putoud Scott Chiossi |
| author_facet | Alexey Kulikov Douglas Webb Dudley Tarlton Toker Ergüder Henrik Khachatryan Nicholas Banatvala Anna Kontsevaya Bekir Keskinkilic John Juliard Go Diana Andreasyan Roy Small Aliina Altymysheva Giuseppe Troisi Roman Chestnov Erwin Arthur Phillips Taraleen Malcolm Hero Kol Nargiza Khodjaeva Mussie Gebremichael Addisu Worku Tessema Asmamaw Bezabeh Workneh Tamu Davidson Michelle Harris Nurgul Ibraeva Aigul Nurmatova Krisada Hanbunjerd Sushera Bunluesin Olivia Nieveras Banu Ekinci Oyoo Charles Akiya Hafisa Kasule Aidah Nakanjako Shukhrat Shukurov Nazokat Kasymova Patrick Banda Ernest Kakoma Nathan N Bakyaita Nadia Putoud Scott Chiossi |
| author_sort | Alexey Kulikov |
| collection | DOAJ |
| description | Non-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact of the investment cases, semistructured interviews and a structured process for gathering written feedback were conducted between July and October 2022 with key informants in 13 countries who had developed a national NCD investment case between 2015 and 2020. Investment cases describe: (1) the social and economic costs of NCDs, including their distribution and projections over time; (2) priority areas for scaled up action; (3) the cost and returns from investing in WHO-recommended measures to prevent and manage NCDs; and (4) the political dimensions of NCD responses. While no country had implemented all the recommendations set out in their investment case reports, actions and policy changes attributable to the investment cases were identified, across (1) governance; (2) financing; and (3) health service access and delivery. The pathways of these changes included: (1) stronger collaboration across government ministries and partners; (2) advocacy for NCD prevention and control; (3) grounding efforts in nationally owned data and evidence; (4) developing mutually embraced ‘language’ across health and finance; and (5) elevating the priority accorded to NCDs, by framing action as an investment rather than a cost. The assessment also identified barriers to progress on the investment case implementation, including the influence of some private sector entities on sectors other than health, the impact of the COVID-19 pandemic, and changes in senior political and technical government officials. The results suggest that national NCD investment cases can significantly contribute to catalysing the prevention and control of NCDs through strengthening governance, financing, and health service access and delivery. |
| first_indexed | 2024-04-24T11:25:54Z |
| format | Article |
| id | doaj.art-b4178eedae8e42cb8f5e37b9842aa320 |
| institution | Directory Open Access Journal |
| issn | 2059-7908 |
| language | English |
| last_indexed | 2024-04-24T11:25:54Z |
| publishDate | 2024-04-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Global Health |
| spelling | doaj.art-b4178eedae8e42cb8f5e37b9842aa3202024-04-10T20:15:09ZengBMJ Publishing GroupBMJ Global Health2059-79082024-04-019410.1136/bmjgh-2023-014784The reported impact of non-communicable disease investment cases in 13 countriesAlexey Kulikov0Douglas Webb1Dudley Tarlton2Toker Ergüder3Henrik Khachatryan4Nicholas Banatvala5Anna Kontsevaya6Bekir Keskinkilic7John Juliard Go8Diana Andreasyan9Roy Small10Aliina Altymysheva11Giuseppe Troisi12Roman Chestnov13Erwin Arthur Phillips14Taraleen Malcolm15Hero Kol16Nargiza Khodjaeva17Mussie Gebremichael18Addisu Worku Tessema19Asmamaw Bezabeh Workneh20Tamu Davidson21Michelle Harris22Nurgul Ibraeva23Aigul Nurmatova24Krisada Hanbunjerd25Sushera Bunluesin26Olivia Nieveras27Banu Ekinci28Oyoo Charles Akiya29Hafisa Kasule30Aidah Nakanjako31Shukhrat Shukurov32Nazokat Kasymova33Patrick Banda34Ernest Kakoma35Nathan N Bakyaita36Nadia Putoud37Scott Chiossi3830 United Nations Inter-Agency Task Force on the Prevention and Control of NCDs, WHO, Geneva, SwitzerlandEvery Woman Every Child Determinants of Health Working Group, Health Section, Unicef, New York 10017, USAHealth and Development, United Nations Development Programme, Geneva, Switzerland22 WHO Türkiye, Ankara, Türkiye4 WHO CO Armenia, World Health Organization Regional Office for Europe, Yerevan, Armenia30 United Nations Inter-Agency Task Force on the Prevention and Control of NCDs, WHO, Geneva, SwitzerlandNational Medical Research Centre for Therapy and Preventive Medicine, Moscow, RussiaDepartment of Cancer Control, Public Health Institute, Turkish Ministry of Health, Ankara, Turkey.1World Health Organization Philippines4 National Institute of Health/National Health Information Analytic Center, Ministry of Health of the Republic of Armenia, Yerevan, Armeniapolicy specialistnational professional officer1 WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt3 International Telecommunication Union, Geneva, Switzerland6 Government of Barbados Ministry of Health & Wellness, Saint Michael, Barbados7 Pan American Health Organization, Washington, District of Columbia, USA8 Department of Preventive Medicine, Royal Government of Cambodia Ministry of Health, Phnom Penh, Cambodia9 WHO Cambodia, Phnom Penh, Cambodia10 Disease Prevention and Control Directorate, Ethiopia Ministry of Health, Addis Ababa, Ethiopia11 Federal Ministry of Health, Addis Ababa, Ethiopia12 WHO Country Office for Ethiopia, Addis Ababa, Ethiopia13 Ministry of Health and Wellness, Kingston, Jamaica7 Pan American Health Organization, Washington, District of Columbia, USA14 Ministry of Health and Social Development of the Kyrgyz Republic, Bishkek, Kyrgyzstan15 Smoke-free Universities, Bishkek, Kyrgyzstan19 Division of NCDs, Department of Disease Control, Royal Thai Government Ministry of Public Health, Bangkok, Thailand20 WHO Thailand, Bangkok, Thailand20 WHO Thailand, Bangkok, Thailand21 Republic of Türkiye Ministry of Health, Cankaya, Türkiye23 Department of NCDs, Republic of Uganda Ministry of Health, Kampala, Uganda24 WHO Country Office for Uganda, Kampala, Uganda25 United Nations Development Programme Uganda, Kampala, Uganda26 Healthy Lifestyle and Physical Activity Support Center, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan27 WHO Uzbekistan, Tashkent, Uzbekistan28 Zambia Ministry of Health, Lusaka, Zambia28 Zambia Ministry of Health, Lusaka, Zambia29 WHO, Lusaka, Zambia32 The Global Fund to Fight AIDS, Tuberculosis and Malaria, Grand-Saconnex, Switzerland30 United Nations Inter-Agency Task Force on the Prevention and Control of NCDs, WHO, Geneva, SwitzerlandNon-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact of the investment cases, semistructured interviews and a structured process for gathering written feedback were conducted between July and October 2022 with key informants in 13 countries who had developed a national NCD investment case between 2015 and 2020. Investment cases describe: (1) the social and economic costs of NCDs, including their distribution and projections over time; (2) priority areas for scaled up action; (3) the cost and returns from investing in WHO-recommended measures to prevent and manage NCDs; and (4) the political dimensions of NCD responses. While no country had implemented all the recommendations set out in their investment case reports, actions and policy changes attributable to the investment cases were identified, across (1) governance; (2) financing; and (3) health service access and delivery. The pathways of these changes included: (1) stronger collaboration across government ministries and partners; (2) advocacy for NCD prevention and control; (3) grounding efforts in nationally owned data and evidence; (4) developing mutually embraced ‘language’ across health and finance; and (5) elevating the priority accorded to NCDs, by framing action as an investment rather than a cost. The assessment also identified barriers to progress on the investment case implementation, including the influence of some private sector entities on sectors other than health, the impact of the COVID-19 pandemic, and changes in senior political and technical government officials. The results suggest that national NCD investment cases can significantly contribute to catalysing the prevention and control of NCDs through strengthening governance, financing, and health service access and delivery.https://gh.bmj.com/content/9/4/e014784.full |
| spellingShingle | Alexey Kulikov Douglas Webb Dudley Tarlton Toker Ergüder Henrik Khachatryan Nicholas Banatvala Anna Kontsevaya Bekir Keskinkilic John Juliard Go Diana Andreasyan Roy Small Aliina Altymysheva Giuseppe Troisi Roman Chestnov Erwin Arthur Phillips Taraleen Malcolm Hero Kol Nargiza Khodjaeva Mussie Gebremichael Addisu Worku Tessema Asmamaw Bezabeh Workneh Tamu Davidson Michelle Harris Nurgul Ibraeva Aigul Nurmatova Krisada Hanbunjerd Sushera Bunluesin Olivia Nieveras Banu Ekinci Oyoo Charles Akiya Hafisa Kasule Aidah Nakanjako Shukhrat Shukurov Nazokat Kasymova Patrick Banda Ernest Kakoma Nathan N Bakyaita Nadia Putoud Scott Chiossi The reported impact of non-communicable disease investment cases in 13 countries BMJ Global Health |
| title | The reported impact of non-communicable disease investment cases in 13 countries |
| title_full | The reported impact of non-communicable disease investment cases in 13 countries |
| title_fullStr | The reported impact of non-communicable disease investment cases in 13 countries |
| title_full_unstemmed | The reported impact of non-communicable disease investment cases in 13 countries |
| title_short | The reported impact of non-communicable disease investment cases in 13 countries |
| title_sort | reported impact of non communicable disease investment cases in 13 countries |
| url | https://gh.bmj.com/content/9/4/e014784.full |
| work_keys_str_mv | AT alexeykulikov thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT douglaswebb thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT dudleytarlton thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT tokererguder thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT henrikkhachatryan thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nicholasbanatvala thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT annakontsevaya thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT bekirkeskinkilic thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT johnjuliardgo thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT dianaandreasyan thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT roysmall thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aliinaaltymysheva thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT giuseppetroisi thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT romanchestnov thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT erwinarthurphillips thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT taraleenmalcolm thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT herokol thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nargizakhodjaeva thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT mussiegebremichael thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT addisuworkutessema thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT asmamawbezabehworkneh thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT tamudavidson thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT michelleharris thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nurgulibraeva thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aigulnurmatova thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT krisadahanbunjerd thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT susherabunluesin thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT olivianieveras thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT banuekinci thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT oyoocharlesakiya thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT hafisakasule thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aidahnakanjako thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT shukhratshukurov thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nazokatkasymova thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT patrickbanda thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT ernestkakoma thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nathannbakyaita thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nadiaputoud thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT scottchiossi thereportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT alexeykulikov reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT douglaswebb reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT dudleytarlton reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT tokererguder reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT henrikkhachatryan reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nicholasbanatvala reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT annakontsevaya reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT bekirkeskinkilic reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT johnjuliardgo reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT dianaandreasyan reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT roysmall reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aliinaaltymysheva reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT giuseppetroisi reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT romanchestnov reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT erwinarthurphillips reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT taraleenmalcolm reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT herokol reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nargizakhodjaeva reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT mussiegebremichael reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT addisuworkutessema reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT asmamawbezabehworkneh reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT tamudavidson reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT michelleharris reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nurgulibraeva reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aigulnurmatova reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT krisadahanbunjerd reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT susherabunluesin reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT olivianieveras reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT banuekinci reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT oyoocharlesakiya reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT hafisakasule reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT aidahnakanjako reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT shukhratshukurov reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nazokatkasymova reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT patrickbanda reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT ernestkakoma reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nathannbakyaita reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT nadiaputoud reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries AT scottchiossi reportedimpactofnoncommunicablediseaseinvestmentcasesin13countries |